Hobart Private Capital, LLC Regeneron Pharmaceuticals, Inc. Transaction History

Hobart Private Capital, LLC

  • $391 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Mar 11, 2024
SELL
$544.75 - $658.21 $272,375 - $329,105
-500 Closed
0 $0
Q2 2020

Mar 11, 2024
SELL
$493.32 - $643.92 $123,823 - $161,623
-251 Reduced 33.42%
500 $312 Million
Q1 2020

Mar 11, 2024
BUY
$336.18 - $494.43 $252,471 - $371,316
751 New
751 $367 Million

Others Institutions Holding REGN

# of Institutions
1,529
Shares Held
84.1M
Call Options Held
1.22M
Put Options Held
1.51M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $81.1B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Hobart Private Capital, LLC Portfolio

Follow Hobart Private Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hobart Private Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hobart Private Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email